Biomedical research at Oslo University Hospital

Oslo University Hospital is a merger of three former university hospitals in Oslo. Biomedical research is one of the hospital's core activities. Research at the hospital is closely interlinked with research undertaken at the University of Oslo. More than 50% of all biomedical research in Norway is published by researchers affiliated with the hospital. Research undertaken cover both basic research, translational research, and clinical research.

Oslo University Hospital has a central role in developing and supporting biomedical research within the South-Eastern Regional Health Authority. The hospital also pursues international research collaborations.

Click here to see hierarchical division and subunit overview

Summary of publications:

Publications (original articles or review articles) published in 2020 from OUS - Institute for Cancer Genetics and Informatics

10 publications found

Bindesbøll C, Aas A, Ogmundsdottir MH, Pankiv S, Reine T, Zoncu R, Simonsen A (2020)
NBEAL1 controls SREBP2 processing and cholesterol metabolism and is a susceptibility locus for coronary artery disease
Sci Rep, 10 (1), 4528
DOI 10.1038/s41598-020-61352-0, PubMed 32161285

Clarke M, Mackay A, Ismer B, Pickles JC, Tatevossian RG, Newman S, Bale TA, Stoler I, Izquierdo E, Temelso S, Carvalho DM, Molinari V, Burford A, Howell L, Virasami A, Fairchild AR, Avery A, Chalker J, Kristiansen M, Haupfear K, Dalton JD, Orisme W, Wen J, Hubank M, Kurian KM et al. (2020)
Infant high grade gliomas comprise multiple subgroups characterized by novel targetable gene fusions and favorable outcomes
Cancer Discov (in press)
DOI 10.1158/2159-8290.CD-19-1030, PubMed 32238360

Jeanmougin M, Håvik AB, Cekaite L, Brandal P, Sveen A, Meling TR, Ågesen TH, Scheie D, Heim S, Lothe RA, Lind GE (2020)
Improved prognostication of glioblastoma beyond molecular subtyping by transcriptional profiling of the tumor microenvironment
Mol Oncol (in press)
DOI 10.1002/1878-0261.12668, PubMed 32171051

Jin Y, Saatcioglu F (2020)
Targeting the Unfolded Protein Response in Hormone-Regulated Cancers
Trends Cancer, 6 (2), 160-171
DOI 10.1016/j.trecan.2019.12.001, PubMed 32061305

Panagopoulos I, Gorunova L, Johannsdottir IMR, Andersen K, Holth A, Beiske K, Heim S (2020)
Chromosome Translocation t(14;21)(q11;q22) Activates Both OLIG1 and OLIG2 in Pediatric T-cell Lymphoblastic Malignancies and May Signify Adverse Prognosis
Cancer Genomics Proteomics, 17 (1), 41-48
DOI 10.21873/cgp.20166, PubMed 31882550

Panagopoulos I, Gorunova L, Kostolomov I, Lobmaier I, Bjerkehagen B, Heim S (2020)
Chronic Expanding Hematoma with a t(11;19)(q13;q13) Chromosomal Translocation
Anticancer Res, 40 (1), 97-100
DOI 10.21873/anticanres.13930, PubMed 31892557

Panagopoulos I, Gorunova L, Lobmaier I, Andersen K, Kostolomov I, Lund-Iversen M, Bjerkehagen B, Heim S (2020)
FOS-ANKH and FOS-RUNX2 Fusion Genes in Osteoblastoma
Cancer Genomics Proteomics, 17 (2), 161-168
DOI 10.21873/cgp.20176, PubMed 32108038

Panagopoulos I, Gorunova L, Rise TV, Andersen K, Micci F, Heim S (2020)
An Unbalanced Chromosome Translocation Between 7p22 and 12q13 Leads to ACTB-GLI1 Fusion in Pericytoma
Anticancer Res, 40 (3), 1239-1245
DOI 10.21873/anticanres.14065, PubMed 32132020

Skrede OJ, De Raedt S, Kleppe A, Hveem TS, Liestøl K, Maddison J, Askautrud HA, Pradhan M, Nesheim JA, Albregtsen F, Farstad IN, Domingo E, Church DN, Nesbakken A, Shepherd NA, Tomlinson I, Kerr R, Novelli M, Kerr DJ, Danielsen HE (2020)
Deep learning for prediction of colorectal cancer outcome: a discovery and validation study
Lancet, 395 (10221), 350-360
DOI 10.1016/S0140-6736(19)32998-8, PubMed 32007170

Stensvold E, Stadskleiv K, Myklebust TÅ, Wesenberg F, Helseth E, Bechensteen AG, Brandal P (2020)
Unmet rehabilitation needs in 86% of Norwegian paediatric embryonal brain tumour survivors
Acta Paediatr
DOI 10.1111/apa.15188, PubMed 31977119

 
Page visits: 351923